MVP.AU Medical Developments International Ltd

Healthcare Pharmaceuticals Australian Securities Exchange
0.3650 AUD
Close of Oct 30, 2026
0.3650 0.7200
Market cap
AUD 41.1M
P/E
36.5x
P/B
0.74x
ROE
1.1%
Dividend yield
-
Fundamental score
2.1/5

Ratios use the latest price and the fiscal year ending Jun 2026.

Is MVP.AU undervalued?

Graham number
Price0.3650
Graham value0.3339
Premium9.3%

MVP.AU trades 9.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Medical Developments International Ltd fundamental analysis

11 of 22 checks passed

ROE 0/2

Low return on equity (1.1%), below 10%.

ROA 1/1

Return on assets (0.9%) is above the industry median (-8.9%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (537.6%) is above the industry median (42.8%).

Revenue Growth 1/2

Revenue grew 9.6% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (3.0%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 16.3x against interest expense, well covered.

PE vs Market 0/1

PE (36.5x) is above the market median (15.0x).

PE vs Industry 0/1

PE (36.5x) is above the industry median (21.9x).

PBV 1/1

Price to book (0.7x) is below the industry median (2.0x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 26.9, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Medical Developments International Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Medical Developments International Ltd

Medical Developments International Limited provides emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The company also supplies respiratory pr…

Full company profile